In the mutant Htt transgenic mouse model of Huntington’s disease, knocking out ATF4 has no effects on Htt aggregation [77] whereas targeting the IRE1 signaling pathways resulted in an improvement in motor performances and reduced Htt accumulation [77,78]. Here, HTT is linked to Huntington disease.